Research reveals new therapeutic targets for Huntington's and Parkinson's disease

March 14, 2014 by Kathy Wallis

(Medical Xpress)—Research from Western University has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviours in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted. The research is published online in Human Molecular Genetics.

HD is an inherited neurodegenerative disorder which causes uncontrolled movement, and eventually cognitive decline and emotional disturbances.

Working in the Ferguson lab where Ribeiro was a postdoctoral trainee, the scientists crossed two mouse models. One was a mouse which doesn't have glutamate receptors –they've been knocked out genetically, and the other is a HD which over-expresses mutant human Huntington protein. They found if they deleted mGluR5, they lost the pathology of Huntington's in the neurons, and they saw improvements in motor behaviour which normally would be impaired in these mice.

The video will load shortly

"What we found was, if we block mGluR5, which is the we're interested in, the mice become hyper locomotive so they become able to move better than wild type mice suggesting glutamate receptors might be a good target for treating movement disorders such as Parkinson's disease. So that was a bit of a surprise that came out in the study, and we can show that genetically and pharmaceutically," says Ferguson who holds a Canada Research Chair in Molecular Neurobiology. "And the good thing is, there are mGluR5 antagonists now in stage three clinical trials for diseases such as Fragile X, so it is quite possible these drugs will be available for patients in the future."

Explore further: Research reveals new therapeutic target for Huntington's disease

Related Stories

Alzheimer's missing link found

September 4, 2013

Yale School of Medicine researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer's disease, they report in the Sept. 4 issue of the journal Neuron. Researchers ...

Research targets brain region affected by Parkinson's

November 8, 2011

A team of researchers at The University of Western Ontario has demonstrated that elimination of one of the neurotransmitters in the part of the brain associated with Parkinson's disease may improve brain function without ...

Recommended for you

Parkinson's disease linked to microbiome

December 1, 2016

Caltech scientists have discovered for the first time a functional link between bacteria in the intestines and Parkinson's disease (PD). The researchers show that changes in the composition of gut bacterial populations—or ...

Parkinson's disease patients benefit from physical activity

November 15, 2016

A comprehensive review published in the Journal of Parkinson's Disease confirms that people living with Parkinson's disease (PD) can benefit from being physically active, especially when it comes to improving gait and balance, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.